VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q40839678 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000237.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q40839678‏
024 ‎‡a 0000-0003-3355-0298‏ ‎‡2 orcid‏
024 ‎‡a 25954462600‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q40839678‏
100 0 ‎‡a Luis C. López‏ ‎‡9 sl‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Luis C. López‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Luis C. López‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
400 0 ‎‡a Luis C. López‏ ‎‡c investigador‏ ‎‡9 es‏
400 0 ‎‡a Luis C. López‏ ‎‡c investigador‏ ‎‡9 ast‏
670 ‎‡a Author's A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease‏
670 ‎‡a Author's A review of the melatonin functions in zebrafish physiology‏
670 ‎‡a Author's Acute and chronic mitochondrial respiratory chain deficiency differentially regulate lysosomal biogenesis.‏
670 ‎‡a Author's ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency‏
670 ‎‡a Author's Age-dependent lipopolysaccharide-induced iNOS expression and multiorgan failure in rats: Effects of melatonin treatment‏
670 ‎‡a Author's Analysis of the daily changes of melatonin receptors in the rat liver‏
670 ‎‡a Author's Antioxidant effect of exercise: Exploring the role of the mitochondrial complex I superassembly.‏
670 ‎‡a Author's Argan oil-contained antioxidants for human mitochondria.‏
670 ‎‡a Author's Assessment of thymidine phosphorylase function: measurement of plasma thymidine‏
670 ‎‡a Author's Assessment of thymidine phosphorylase function: measurement of plasma thymidine (and deoxyuridine) and thymidine phosphorylase activity‏
670 ‎‡a Author's Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice‏
670 ‎‡a Author's Bypassing human CoQ10 deficiency‏
670 ‎‡a Author's Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture‏
670 ‎‡a Author's Chronic melatonin treatment prevents age-dependent cardiac mitochondrial dysfunction in senescence-accelerated mice.‏
670 ‎‡a Author's Chronic melatonin treatment reduces the age-dependent inflammatory process in senescence-accelerated mice.‏
670 ‎‡a Author's Clinical and genetic analysis of lipid storage myopathies‏
670 ‎‡a Author's Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation‏
670 ‎‡a Author's Composition and Antioxidant Properties of Spanish Extra Virgin Olive Oil Regarding Cultivar, Harvest Year and Crop Stage‏
670 ‎‡a Author's CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome.‏
670 ‎‡a Author's CoQ10 supplementation rescues nephrotic syndrome through normalization of H2S oxidation pathway‏
670 ‎‡a Author's Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function.‏
670 ‎‡a Author's Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.‏
670 ‎‡a Author's Detection of 6-demethoxyubiquinone in CoQ10 deficiency disorders: Insights into enzyme interactions and identification of potential therapeutics.‏
670 ‎‡a Author's Determination of Coenzyme Q10, Coenzyme Q9, and Melatonin Contents in Virgin Argan Oils: Comparison with Other Edible Vegetable Oils‏
670 ‎‡a Author's Disruption of the NF-κB/NLRP3 connection by melatonin requires retinoid-related orphan receptor-α and blocks the septic response in mice‏
670 ‎‡a Author's Dysfunctional Coq9 protein causes predominant encephalomyopathy associated with CoQ deficiency‏
670 ‎‡a Author's Early gender differences in the redox status of the brain mitochondria with age: effects of melatonin therapy.‏
670 ‎‡a Author's ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency‏
670 ‎‡a Author's Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations‏
670 ‎‡a Author's Extrapineal melatonin: sources, regulation, and potential functions.‏
670 ‎‡a Author's Gene Therapy Corrects Mitochondrial Dysfunction in Hematopoietic Progenitor Cells and Fibroblasts from Coq9R239X Mice.‏
670 ‎‡a Author's Heterogeneity of coenzyme Q10 deficiency: patient study and literature review‏
670 ‎‡a Author's Hydroxytyrosol influences exercise-induced mitochondrial respiratory complex assembly into supercomplexes in rats‏
670 ‎‡a Author's Identification of an inducible nitric oxide synthase in diaphragm mitochondria from septic mice: its relation with mitochondrial dysfunction and prevention by melatonin.‏
670 ‎‡a Author's Identification of mitochondrial deficits and melatonin targets in liver of septic mice by high-resolution respirometry.‏
670 ‎‡a Author's Identification of morphological markers of sarcopenia at early stage of aging in skeletal muscle of mice.‏
670 ‎‡a Author's Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice.‏
670 ‎‡a Author's In Vivo Determination of Mitochondrial Respiration in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Zebrafish Reveals the Efficacy of Melatonin in Restoring Mitochondrial Normalcy.‏
670 ‎‡a Author's Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin‏
670 ‎‡a Author's Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway.‏
670 ‎‡a Author's Lack of NLRP3 Inflammasome Activation Reduces Age-Dependent Sarcopenia and Mitochondrial Dysfunction, Favoring the Prophylactic Effect of Melatonin‏
670 ‎‡a Author's Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations‏
670 ‎‡a Author's Long-term melatonin administration protects brain mitochondria from aging.‏
670 ‎‡a Author's Mechanisms of N-methyl-D-aspartate receptor inhibition by melatonin in the rat striatum‏
670 ‎‡a Author's Melatonin administration to wild-type mice and nontreated NLRP3 mutant mice share similar inhibition of the inflammatory response during sepsis.‏
670 ‎‡a Author's Melatonin and its brain metabolite N‏
670 ‎‡a Author's Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice.‏
670 ‎‡a Author's Melatonin blunts the mitochondrial/NLRP3 connection and protects against radiation-induced oral mucositis‏
670 ‎‡a Author's Melatonin, clock genes and mitochondria in sepsis.‏
670 ‎‡a Author's Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice.‏
670 ‎‡a Author's Melatonin Enhances Cisplatin and Radiation Cytotoxicity in Head and Neck Squamous Cell Carcinoma by Stimulating Mitochondrial ROS Generation, Apoptosis, and Autophagy‏
670 ‎‡a Author's Melatonin enhances neural stem cell differentiation and engraftment by increasing mitochondrial function.‏
670 ‎‡a Author's Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse‏
670 ‎‡a Author's Melatonin protects rats from radiotherapy-induced small intestine toxicity‏
670 ‎‡a Author's Melatonin rescues zebrafish embryos from the parkinsonian phenotype restoring the parkin/PINK1/DJ-1/MUL1 network‏
670 ‎‡a Author's Melatonin restores the mitochondrial production of ATP in septic mice‏
670 ‎‡a Author's Melatonin role in the mitochondrial function.‏
670 ‎‡a Author's Melatonin treatment counteracts the hyperoxidative status in erythrocytes of patients suffering from Duchenne muscular dystrophy‏
670 ‎‡a Author's Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy‏
670 ‎‡a Author's Mitochondrial DNA and inflammatory diseases.‏
670 ‎‡a Author's Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases‏
670 ‎‡a Author's Oxidative stress status, clinical outcome, and β-globin gene cluster haplotypes in pediatric patients with sickle cell disease.‏
670 ‎‡a Author's Pathomechanisms in coenzyme q10-deficient human fibroblasts‏
670 ‎‡a Author's Permeabilized myocardial fibers as model to detect mitochondrial dysfunction during sepsis and melatonin effects without disruption of mitochondrial network‏
670 ‎‡a Author's Protective effects of melatonin against oxidative damage induced by Egyptian cobra‏
670 ‎‡a Author's Protective effects of melatonin against oxidative damage induced by Egyptian cobra (Naja haje) crude venom in rats‏
670 ‎‡a Author's Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice‏
670 ‎‡a Author's Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease‏
670 ‎‡a Author's Reduction in the levels of CoQ biosynthetic proteins is related to an increase in lifespan without evidence of hepatic mitohormesis‏
670 ‎‡a Author's Same molecule but different expression: aging and sepsis trigger NLRP3 inflammasome activation, a target of melatonin.‏
670 ‎‡a Author's Synergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide‏
670 ‎‡a Author's The beneficial effects of melatonin against heart mitochondrial impairment during sepsis: inhibition of iNOS and preservation of nNOS.‏
670 ‎‡a Author's The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene.‏
670 ‎‡a Author's The Protective Effect of Melatonin Against Age-Associated Sarcopenia-Dependent Tubular Aggregates Formation, Lactate Depletion and Mitochondrial Changes.‏
670 ‎‡a Author's The Q-junction and the inflammatory response are critical pathological and therapeutic factors in CoQ deficiency‏
670 ‎‡a Author's The Role of Sulfide Oxidation Impairment in the Pathogenesis of Primary CoQ Deficiency‏
670 ‎‡a Author's Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)‏
670 ‎‡a Author's Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance.‏
670 ‎‡a Author's Treatment of CoQ(10) deficient fibroblasts with ubiquinone, CoQ analogs, and vitamin C: time- and compound-dependent effects‏
670 ‎‡a Author's Treatment of CoQ10 Deficient Fibroblasts with Ubiquinone, CoQ Analogs, and Vitamin C: Time- and Compound-Dependent Effects‏
670 ‎‡a Author's Ubiquinol-10 ameliorates mitochondrial encephalopathy associated with CoQ deficiency‏
670 ‎‡a Author's β-RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in mice‏
909 ‎‡a (orcid) 0000000333550298‏ ‎‡9 1‏
909 ‎‡a (scopus) 25954462600‏ ‎‡9 1‏
919 ‎‡a protectiveeffectsofsynthetickynurenineson1methyl4phenyl1236tetrahydropyridineinducedparkinsonisminmice‏ ‎‡A Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice‏ ‎‡9 1‏
919 ‎‡a protectiveeffectsofmelatoninagainstoxidativedamageinducedbyegyptiancobra‏ ‎‡A Protective effects of melatonin against oxidative damage induced by Egyptian cobra‏ ‎‡9 1‏
919 ‎‡a permeabilizedmyocardialfibersasmodeltodetectmitochondrialdysfunctionduringsepsisandmelatonineffectswithoutdisruptionofmitochondrialnetwork‏ ‎‡A Permeabilized myocardial fibers as model to detect mitochondrial dysfunction during sepsis and melatonin effects without disruption of mitochondrial network‏ ‎‡9 1‏
919 ‎‡a pathomechanismsincoenzymeq10deficienthumanfibroblasts‏ ‎‡A Pathomechanisms in coenzyme q10-deficient human fibroblasts‏ ‎‡9 1‏
919 ‎‡a oxidativestressstatusclinicaloutcomeandβglobingeneclusterhaplotypesinpediatricpatientswithsicklecelldisease‏ ‎‡A Oxidative stress status, clinical outcome, and β-globin gene cluster haplotypes in pediatric patients with sickle cell disease.‏ ‎‡9 1‏
919 ‎‡a mitochondrialimpairmentandmelatoninprotectioninparkinsonianmicedonotdependofinducibleorneuronalnitricoxidesynthases‏ ‎‡A Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases‏ ‎‡9 1‏
919 ‎‡a mitochondrialdnaandinflammatorydiseases‏ ‎‡A Mitochondrial DNA and inflammatory diseases.‏ ‎‡9 1‏
919 ‎‡a melatonintreatmentnormalizesplasmaproinflammatorycytokinesandnitrosativeoxidativestressinpatientssufferingfromduchennemusculardystrophy‏ ‎‡A Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy‏ ‎‡9 1‏
919 ‎‡a melatonintreatmentcounteractsthehyperoxidativestatusinerythrocytesofpatientssufferingfromduchennemusculardystrophy‏ ‎‡A Melatonin treatment counteracts the hyperoxidative status in erythrocytes of patients suffering from Duchenne muscular dystrophy‏ ‎‡9 1‏
919 ‎‡a melatoninroleinthemitochondrialfunction‏ ‎‡A Melatonin role in the mitochondrial function.‏ ‎‡9 1‏
919 ‎‡a melatoninrestoresthemitochondrialproductionofatpinsepticmice‏ ‎‡A Melatonin restores the mitochondrial production of ATP in septic mice‏ ‎‡9 1‏
919 ‎‡a melatoninrescueszebrafishembryosfromtheparkinsonianphenotyperestoringtheparkinpink1dj1mul1network‏ ‎‡A Melatonin rescues zebrafish embryos from the parkinsonian phenotype restoring the parkin/PINK1/DJ-1/MUL1 network‏ ‎‡9 1‏
919 ‎‡a melatoninprotectsratsfromradiotherapyinducedsmallintestinetoxicity‏ ‎‡A Melatonin protects rats from radiotherapy-induced small intestine toxicity‏ ‎‡9 1‏
919 ‎‡a melatoninplusphysicalexercisearehighlyneuroprotectiveinthe3xtgadmouse‏ ‎‡A Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse‏ ‎‡9 1‏
919 ‎‡a melatoninenhancesneuralstemcelldifferentiationandengraftmentbyincreasingmitochondrialfunction‏ ‎‡A Melatonin enhances neural stem cell differentiation and engraftment by increasing mitochondrial function.‏ ‎‡9 1‏
919 ‎‡a coqdeficiencycausesdisruptionofmitochondrialsulfideoxidationanewpathomechanismassociatedwiththissyndrome‏ ‎‡A CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome.‏ ‎‡9 1‏
919 ‎‡a coq10supplementationrescuesnephroticsyndromethroughnormalizationofh2soxidationpathway‏ ‎‡A CoQ10 supplementation rescues nephrotic syndrome through normalization of H2S oxidation pathway‏ ‎‡9 1‏
919 ‎‡a cordbloodderivedcd34+hematopoieticcellswithlowmitochondrialmassareenrichedinhematopoieticrepopulatingstemcellfunction‏ ‎‡A Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function.‏ ‎‡9 1‏
919 ‎‡a deoxypyrimidinemonophosphatebypasstherapyforthymidinekinase2deficiency‏ ‎‡A Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.‏ ‎‡9 1‏
919 ‎‡a detectionof6demethoxyubiquinoneincoq10deficiencydisordersinsightsintoenzymeinteractionsandidentificationofpotentialtherapeutics‏ ‎‡A Detection of 6-demethoxyubiquinone in CoQ10 deficiency disorders: Insights into enzyme interactions and identification of potential therapeutics.‏ ‎‡9 1‏
919 ‎‡a determinationofcoenzymeq10coenzymeq9andmelatonincontentsinvirginarganoilscomparisonwithotherediblevegetableoils‏ ‎‡A Determination of Coenzyme Q10, Coenzyme Q9, and Melatonin Contents in Virgin Argan Oils: Comparison with Other Edible Vegetable Oils‏ ‎‡9 1‏
919 ‎‡a disruptionofthenfκbnlrp3connectionbymelatoninrequiresretinoidrelatedorphanreceptorαandblocksthesepticresponseinmice‏ ‎‡A Disruption of the NF-κB/NLRP3 connection by melatonin requires retinoid-related orphan receptor-α and blocks the septic response in mice‏ ‎‡9 1‏
919 ‎‡a dysfunctionalcoq9proteincausespredominantencephalomyopathyassociatedwithcoqdeficiency‏ ‎‡A Dysfunctional Coq9 protein causes predominant encephalomyopathy associated with CoQ deficiency‏ ‎‡9 1‏
919 ‎‡a earlygenderdifferencesintheredoxstatusofthebrainmitochondriawithageeffectsofmelatonintherapy‏ ‎‡A Early gender differences in the redox status of the brain mitochondria with age: effects of melatonin therapy.‏ ‎‡9 1‏
919 ‎‡a etfdhmutationscoq10levelsandrespiratorychainactivitiesinpatientswithriboflavinresponsivemultipleacylcoadehydrogenasedeficiency‏ ‎‡A ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency‏ ‎‡9 1‏
919 ‎‡a extrapinealmelatoninanalysisofitssubcellulardistributionanddailyfluctuations‏ ‎‡A Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations‏ ‎‡9 1‏
919 ‎‡a extrapinealmelatoninsourcesregulationandpotentialfunctions‏ ‎‡A Extrapineal melatonin: sources, regulation, and potential functions.‏ ‎‡9 1‏
919 ‎‡a genetherapycorrectsmitochondrialdysfunctioninhematopoieticprogenitorcellsandfibroblastsfromcoq9r239xmice‏ ‎‡A Gene Therapy Corrects Mitochondrial Dysfunction in Hematopoietic Progenitor Cells and Fibroblasts from Coq9R239X Mice.‏ ‎‡9 1‏
919 ‎‡a heterogeneityofcoenzymeq10deficiencypatientstudyandliteraturereview‏ ‎‡A Heterogeneity of coenzyme Q10 deficiency: patient study and literature review‏ ‎‡9 1‏
919 ‎‡a hydroxytyrosolinfluencesexerciseinducedmitochondrialrespiratorycomplexassemblyintosupercomplexesinrats‏ ‎‡A Hydroxytyrosol influences exercise-induced mitochondrial respiratory complex assembly into supercomplexes in rats‏ ‎‡9 1‏
919 ‎‡a identificationofaninduciblenitricoxidesynthaseindiaphragmmitochondriafromsepticmiceitsrelationwithmitochondrialdysfunctionandpreventionbymelatonin‏ ‎‡A Identification of an inducible nitric oxide synthase in diaphragm mitochondria from septic mice: its relation with mitochondrial dysfunction and prevention by melatonin.‏ ‎‡9 1‏
919 ‎‡a compositionandantioxidantpropertiesofspanishextravirginoliveoilregardingcultivarharvestyearandcropstage‏ ‎‡A Composition and Antioxidant Properties of Spanish Extra Virgin Olive Oil Regarding Cultivar, Harvest Year and Crop Stage‏ ‎‡9 1‏
919 ‎‡a protectiveeffectsofmelatoninagainstoxidativedamageinducedbyegyptiancobranajahajecrudevenominrats‏ ‎‡A Protective effects of melatonin against oxidative damage induced by Egyptian cobra (Naja haje) crude venom in rats‏ ‎‡9 1‏
919 ‎‡a identificationofmitochondrialdeficitsandmelatonintargetsinliverofsepticmicebyhighresolutionrespirometry‏ ‎‡A Identification of mitochondrial deficits and melatonin targets in liver of septic mice by high-resolution respirometry.‏ ‎‡9 1‏
919 ‎‡a identificationofmorphologicalmarkersofsarcopeniaatearlystageofaginginskeletalmuscleofmice‏ ‎‡A Identification of morphological markers of sarcopenia at early stage of aging in skeletal muscle of mice.‏ ‎‡9 1‏
919 ‎‡a improvedmitochondrialfunctionandincreasedlifespanafterchronicmelatonintreatmentinsenescentpronemice‏ ‎‡A Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice.‏ ‎‡9 1‏
919 ‎‡a invivodeterminationofmitochondrialrespirationin1methyl4phenyl1236tetrahydropyridinetreatedzebrafishrevealstheefficacyofmelatonininrestoringmitochondrialnormalcy‏ ‎‡A In Vivo Determination of Mitochondrial Respiration in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Zebrafish Reveals the Efficacy of Melatonin in Restoring Mitochondrial Normalcy.‏ ‎‡9 1‏
919 ‎‡a inhibitionofneuronalnitricoxidesynthaseactivitybyn1acetyl5methoxykynuramineabrainmetaboliteofmelatonin‏ ‎‡A Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin‏ ‎‡9 1‏
919 ‎‡a lackofaprataxinimpairsmitochondrialfunctionsviadownregulationoftheape1nrf1nrf2pathway‏ ‎‡A Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway.‏ ‎‡9 1‏
919 ‎‡a lackofnlrp3inflammasomeactivationreducesagedependentsarcopeniaandmitochondrialdysfunctionfavoringtheprophylacticeffectofmelatonin‏ ‎‡A Lack of NLRP3 Inflammasome Activation Reduces Age-Dependent Sarcopenia and Mitochondrial Dysfunction, Favoring the Prophylactic Effect of Melatonin‏ ‎‡9 1‏
919 ‎‡a leighsyndromewithnephropathyandcoq10deficiencyduetodecaprenyldiphosphatesynthasesubunit2pdss2mutations‏ ‎‡A Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations‏ ‎‡9 1‏
919 ‎‡a longtermmelatoninadministrationprotectsbrainmitochondriafromaging‏ ‎‡A Long-term melatonin administration protects brain mitochondria from aging.‏ ‎‡9 1‏
919 ‎‡a mechanismsofnmethyl500aspartatereceptorinhibitionbymelatoninintheratstriatum‏ ‎‡A Mechanisms of N-methyl-D-aspartate receptor inhibition by melatonin in the rat striatum‏ ‎‡9 1‏
919 ‎‡a melatoninadministrationtowildtypemiceandnontreatednlrp3mutantmicesharesimilarinhibitionoftheinflammatoryresponseduringsepsis‏ ‎‡A Melatonin administration to wild-type mice and nontreated NLRP3 mutant mice share similar inhibition of the inflammatory response during sepsis.‏ ‎‡9 1‏
919 ‎‡a melatoninanditsbrainmetaboliten‏ ‎‡A Melatonin and its brain metabolite N‏ ‎‡9 1‏
919 ‎‡a melatoninanditsbrainmetaboliten1acetyl5methoxykynuraminepreventmitochondrialnitricoxidesynthaseinductioninparkinsonianmice‏ ‎‡A Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice.‏ ‎‡9 1‏
919 ‎‡a melatoninbluntsthemitochondrialnlrp3connectionandprotectsagainstradiationinducedoralmucositis‏ ‎‡A Melatonin blunts the mitochondrial/NLRP3 connection and protects against radiation-induced oral mucositis‏ ‎‡9 1‏
919 ‎‡a melatoninclockgenesandmitochondriainsepsis‏ ‎‡A Melatonin, clock genes and mitochondria in sepsis.‏ ‎‡9 1‏
919 ‎‡a melatonincounteractsinduciblemitochondrialnitricoxidesynthasedependentmitochondrialdysfunctioninskeletalmuscleofsepticmice‏ ‎‡A Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice.‏ ‎‡9 1‏
919 ‎‡a melatoninenhancescisplatinandradiationcytotoxicityinheadandnecksquamouscellcarcinomabystimulatingmitochondrialrosgenerationapoptosisandautophagy‏ ‎‡A Melatonin Enhances Cisplatin and Radiation Cytotoxicity in Head and Neck Squamous Cell Carcinoma by Stimulating Mitochondrial ROS Generation, Apoptosis, and Autophagy‏ ‎‡9 1‏
919 ‎‡a combinationofmelatoninandrapamycinforheadandneckcancertherapysuppressionofaktmtorpathwayactivationandactivationofmitophagyandapoptosisviamitochondrialfunctionregulation‏ ‎‡A Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation‏ ‎‡9 1‏
919 ‎‡a clinicalandgeneticanalysisoflipidstoragemyopathies‏ ‎‡A Clinical and genetic analysis of lipid storage myopathies‏ ‎‡9 1‏
919 ‎‡a chronicmelatonintreatmentreducestheagedependentinflammatoryprocessinsenescenceacceleratedmice‏ ‎‡A Chronic melatonin treatment reduces the age-dependent inflammatory process in senescence-accelerated mice.‏ ‎‡9 1‏
919 ‎‡a chronicmelatonintreatmentpreventsagedependentcardiacmitochondrialdysfunctioninsenescenceacceleratedmice‏ ‎‡A Chronic melatonin treatment prevents age-dependent cardiac mitochondrial dysfunction in senescence-accelerated mice.‏ ‎‡9 1‏
919 ‎‡a cellularmechanismsinvolvedinthemelatonininhibitionofht29humancoloncancercellproliferationinculture‏ ‎‡A Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture‏ ‎‡9 1‏
919 ‎‡a bypassinghumancoq10deficiency‏ ‎‡A Bypassing human CoQ10 deficiency‏ ‎‡9 1‏
919 ‎‡a attenuationofcardiacmitochondrialdysfunctionbymelatonininsepticmice‏ ‎‡A Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice‏ ‎‡9 1‏
919 ‎‡a assessmentofthymidinephosphorylasefunctionmeasurementofplasmathymidineanddeoxyuridineandthymidinephosphorylaseactivity‏ ‎‡A Assessment of thymidine phosphorylase function: measurement of plasma thymidine (and deoxyuridine) and thymidine phosphorylase activity‏ ‎‡9 1‏
919 ‎‡a assessmentofthymidinephosphorylasefunctionmeasurementofplasmathymidine‏ ‎‡A Assessment of thymidine phosphorylase function: measurement of plasma thymidine‏ ‎‡9 1‏
919 ‎‡a arganoilcontainedantioxidantsforhumanmitochondria‏ ‎‡A Argan oil-contained antioxidants for human mitochondria.‏ ‎‡9 1‏
919 ‎‡a antioxidanteffectofexerciseexploringtheroleofthemitochondrialcomplex1superassembly‏ ‎‡A Antioxidant effect of exercise: Exploring the role of the mitochondrial complex I superassembly.‏ ‎‡9 1‏
919 ‎‡a analysisofthedailychangesofmelatoninreceptorsintheratliver‏ ‎‡A Analysis of the daily changes of melatonin receptors in the rat liver‏ ‎‡9 1‏
919 ‎‡a agedependentlipopolysaccharideinducedinosexpressionandmultiorganfailureinratseffectsofmelatonintreatment‏ ‎‡A Age-dependent lipopolysaccharide-induced iNOS expression and multiorgan failure in rats: Effects of melatonin treatment‏ ‎‡9 1‏
919 ‎‡a adck3anancestralkinaseismutatedinaformofrecessiveataxiaassociatedwithcoenzymeq10deficiency‏ ‎‡A ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency‏ ‎‡9 1‏
919 ‎‡a acuteandchronicmitochondrialrespiratorychaindeficiencydifferentiallyregulatelysosomalbiogenesis‏ ‎‡A Acute and chronic mitochondrial respiratory chain deficiency differentially regulate lysosomal biogenesis.‏ ‎‡9 1‏
919 ‎‡a reviewofthemelatoninfunctionsinzebrafishphysiology‏ ‎‡A A review of the melatonin functions in zebrafish physiology‏ ‎‡9 1‏
919 ‎‡a nonsensemutationincoq9causesautosomalrecessiveneonatalonsetprimarycoenzymeq10deficiencyapotentiallytreatableformofmitochondrialdisease‏ ‎‡A A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease‏ ‎‡9 1‏
919 ‎‡a βrareducesdmqcoqratioandrescuestheencephalopathicphenotypeinmice‏ ‎‡A β-RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in mice‏ ‎‡9 1‏
919 ‎‡a ubiquinol10amelioratesmitochondrialencephalopathyassociatedwithcoqdeficiency‏ ‎‡A Ubiquinol-10 ameliorates mitochondrial encephalopathy associated with CoQ deficiency‏ ‎‡9 1‏
919 ‎‡a treatmentofcoq10deficientfibroblastswithubiquinonecoqanalogsandvitamin100timeandcompounddependenteffects‏ ‎‡A Treatment of CoQ10 Deficient Fibroblasts with Ubiquinone, CoQ Analogs, and Vitamin C: Time- and Compound-Dependent Effects‏ ‎‡9 2‏
919 ‎‡a thymidinekinase2h126nknockinmiceshowtheessentialroleofbalanceddeoxynucleotidepoolsformitochondrialdnamaintenance‏ ‎‡A Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance.‏ ‎‡9 1‏
919 ‎‡a thymidineanddeoxyuridineaccumulateintissuesofpatientswithmitochondrialneurogastrointestinalencephalomyopathymngie‏ ‎‡A Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)‏ ‎‡9 1‏
919 ‎‡a roleofsulfideoxidationimpairmentinthepathogenesisofprimarycoqdeficiency‏ ‎‡A The Role of Sulfide Oxidation Impairment in the Pathogenesis of Primary CoQ Deficiency‏ ‎‡9 1‏
919 ‎‡a qjunctionandtheinflammatoryresponsearecriticalpathologicalandtherapeuticfactorsincoqdeficiency‏ ‎‡A The Q-junction and the inflammatory response are critical pathological and therapeutic factors in CoQ deficiency‏ ‎‡9 1‏
919 ‎‡a protectiveeffectofmelatoninagainstageassociatedsarcopeniadependenttubularaggregatesformationlactatedepletionandmitochondrialchanges‏ ‎‡A The Protective Effect of Melatonin Against Age-Associated Sarcopenia-Dependent Tubular Aggregates Formation, Lactate Depletion and Mitochondrial Changes.‏ ‎‡9 1‏
919 ‎‡a clinicalheterogeneityofcoenzymeq10deficiencyresultsfromgenotypicdifferencesinthecoq9gene‏ ‎‡A The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene.‏ ‎‡9 1‏
919 ‎‡a beneficialeffectsofmelatoninagainstheartmitochondrialimpairmentduringsepsisinhibitionofinosandpreservationofnnos‏ ‎‡A The beneficial effects of melatonin against heart mitochondrial impairment during sepsis: inhibition of iNOS and preservation of nNOS.‏ ‎‡9 1‏
919 ‎‡a synergismbetweenmelatoninandatorvastatinagainstendothelialcelldamageinducedbylipopolysaccharide‏ ‎‡A Synergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide‏ ‎‡9 1‏
919 ‎‡a samemoleculebutdifferentexpressionagingandsepsistriggernlrp3inflammasomeactivationatargetofmelatonin‏ ‎‡A Same molecule but different expression: aging and sepsis trigger NLRP3 inflammasome activation, a target of melatonin.‏ ‎‡9 1‏
919 ‎‡a reductioninthelevelsofcoqbiosyntheticproteinsisrelatedtoanincreaseinlifespanwithoutevidenceofhepaticmitohormesis‏ ‎‡A Reduction in the levels of CoQ biosynthetic proteins is related to an increase in lifespan without evidence of hepatic mitohormesis‏ ‎‡9 1‏
919 ‎‡a rapamycinadministrationisnotavalidtherapeuticstrategyforeverycaseofmitochondrialdisease‏ ‎‡A Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 BNE|XX5638197‏
996 ‎‡2 NII|DA04494387‏
996 ‎‡2 BNC|981058508559506706‏
996 ‎‡2 LC|ns2012000057‏
996 ‎‡2 BNE|XX1036338‏
996 ‎‡2 ISNI|0000000456406819‏
996 ‎‡2 LC|no2009138336‏
996 ‎‡2 ISNI|0000000041626772‏
996 ‎‡2 PLWABN|9812456388005606‏
996 ‎‡2 DNB|1033288705‏
996 ‎‡2 SUDOC|257326073‏
996 ‎‡2 BNF|17962761‏
996 ‎‡2 BNE|XX1004205‏
996 ‎‡2 DNB|1018888063‏
996 ‎‡2 BNE|XX1685142‏
996 ‎‡2 BNF|14462760‏
996 ‎‡2 LC|n 50012313‏
996 ‎‡2 BIBSYS|4003387‏
996 ‎‡2 J9U|987012747881605171‏
996 ‎‡2 SUDOC|191352594‏
996 ‎‡2 BNE|XX1626316‏
996 ‎‡2 NTA|183780035‏
996 ‎‡2 NTA|132063875‏
996 ‎‡2 NTA|186894082‏
996 ‎‡2 ISNI|0000000060764695‏
996 ‎‡2 LC|no2008048786‏
996 ‎‡2 DNB|140691928‏
996 ‎‡2 LC|n 2015019886‏
996 ‎‡2 SELIBR|334653‏
996 ‎‡2 BNC|981060885881906706‏
996 ‎‡2 DNB|118956264‏
996 ‎‡2 BNCHL|10000000000000000055506‏
996 ‎‡2 ISNI|0000000059414102‏
996 ‎‡2 ISNI|0000000079723009‏
996 ‎‡2 BNE|XX1045129‏
996 ‎‡2 PTBNP|1176531‏
996 ‎‡2 NKC|ola2011661635‏
996 ‎‡2 BAV|495_222692‏
996 ‎‡2 BNC|981058510029006706‏
996 ‎‡2 BNE|XX1140079‏
996 ‎‡2 LC|no2008021867‏
996 ‎‡2 NKC|pag20201084477‏
996 ‎‡2 ISNI|0000000118452636‏
996 ‎‡2 BNF|12174910‏
996 ‎‡2 LC|n 2001014612‏
996 ‎‡2 BNE|XX6036270‏
996 ‎‡2 BNE|XX979233‏
996 ‎‡2 ISNI|0000000049578306‏
996 ‎‡2 BNE|XX969879‏
996 ‎‡2 ISNI|0000000121466174‏
996 ‎‡2 LC|n 98015581‏
996 ‎‡2 DNB|1057118613‏
996 ‎‡2 BNE|XX1725379‏
996 ‎‡2 J9U|987007431713305171‏
996 ‎‡2 BNE|XX1393096‏
996 ‎‡2 BNE|XX6136685‏
996 ‎‡2 LC|n 2008031404‏
996 ‎‡2 NTA|174450745‏
996 ‎‡2 BNC|981061141762106706‏
996 ‎‡2 ISNI|000000012139043X‏
996 ‎‡2 NUKAT|n 2016046604‏
996 ‎‡2 ISNI|0000000108839941‏
996 ‎‡2 CAOONL|ncf10705106‏
996 ‎‡2 SUDOC|169092577‏
996 ‎‡2 SUDOC|230808301‏
996 ‎‡2 LC|n 2007080600‏
996 ‎‡2 ISNI|0000000035907383‏
996 ‎‡2 SUDOC|151305242‏
996 ‎‡2 BNC|981058507886606706‏
996 ‎‡2 ISNI|0000000059380352‏
996 ‎‡2 DNB|1069804185‏
996 ‎‡2 BNE|XX5157614‏
996 ‎‡2 DNB|1057421626‏
996 ‎‡2 BNE|XX5125798‏
996 ‎‡2 RERO|A000006129‏
996 ‎‡2 LC|nr 94008761‏
996 ‎‡2 LC|n 2013188907‏
996 ‎‡2 LC|ns2019002823‏
996 ‎‡2 PLWABN|9812836534905606‏
996 ‎‡2 BNE|XX1005001‏
996 ‎‡2 BNE|XX5134675‏
996 ‎‡2 NII|DA09913589‏
996 ‎‡2 DNB|138654042‏
996 ‎‡2 BNE|XX4989119‏
996 ‎‡2 NUKAT|n 2019061343‏
996 ‎‡2 ISNI|0000000427880220‏
996 ‎‡2 LC|no2011101042‏
996 ‎‡2 ISNI|0000000443615013‏
996 ‎‡2 LC|ns2014000889‏
996 ‎‡2 RERO|A012320095‏
996 ‎‡2 ISNI|0000000431775917‏
996 ‎‡2 NSK|000717354‏
996 ‎‡2 BNF|12403514‏
996 ‎‡2 LC|ns2014000644‏
996 ‎‡2 ISNI|000000008143955X‏
996 ‎‡2 BNC|981058520757306706‏
996 ‎‡2 LC|no2007136106‏
996 ‎‡2 LC|nr 94040124‏
996 ‎‡2 DNB|1056647051‏
996 ‎‡2 BNE|XX4802109‏
996 ‎‡2 ISNI|000000003818247X‏
996 ‎‡2 ISNI|0000000066213624‏
996 ‎‡2 DNB|1056646330‏
996 ‎‡2 SUDOC|234578084‏
996 ‎‡2 SUDOC|279189877‏
996 ‎‡2 LC|n 85828180‏
996 ‎‡2 ISNI|0000000079712609‏
996 ‎‡2 ISNI|0000000028401253‏
996 ‎‡2 NTA|074608347‏
996 ‎‡2 LC|no2008075407‏
996 ‎‡2 BNC|981058615427706706‏
996 ‎‡2 BNF|16785331‏
996 ‎‡2 ISNI|0000000038064529‏
996 ‎‡2 CAOONL|ncf11577805‏
996 ‎‡2 LC|no 99073825‏
996 ‎‡2 NTA|073277495‏
996 ‎‡2 NUKAT|n 2010006076‏
996 ‎‡2 LC|no2021062004‏
996 ‎‡2 LC|no2005030760‏
996 ‎‡2 LC|no2011089850‏
996 ‎‡2 LC|n 2020071419‏
996 ‎‡2 ISNI|0000000075515974‏
996 ‎‡2 BNE|XX994731‏
996 ‎‡2 BNE|XX4845070‏
996 ‎‡2 ARBABN|000040500‏
996 ‎‡2 BNE|XX6320771‏
996 ‎‡2 ISNI|0000000116751851‏
996 ‎‡2 BNE|XX1506237‏
996 ‎‡2 LC|n 97091750‏
996 ‎‡2 BNCHL|10000000000000000233225‏
996 ‎‡2 DNB|1057415111‏
996 ‎‡2 BNE|XX1065030‏
996 ‎‡2 BAV|495_188032‏
996 ‎‡2 BNC|981060037975606706‏
996 ‎‡2 LC|no2014018256‏
996 ‎‡2 ISNI|0000000109223591‏
996 ‎‡2 ISNI|0000000060026414‏
996 ‎‡2 ISNI|0000000436112792‏
996 ‎‡2 CAOONL|ncf10249870‏
996 ‎‡2 BNE|XX5050508‏
996 ‎‡2 BNC|981058512876406706‏
996 ‎‡2 DNB|119203480‏
996 ‎‡2 DBC|87097990724517‏
996 ‎‡2 J9U|987007600114305171‏
996 ‎‡2 ISNI|0000000059095893‏
996 ‎‡2 BNC|981058520919406706‏
996 ‎‡2 BNC|981058507597806706‏
996 ‎‡2 SUDOC|250607158‏
996 ‎‡2 ISNI|0000000041798048‏
996 ‎‡2 SUDOC|058652175‏
996 ‎‡2 ISNI|0000000060491500‏
996 ‎‡2 PTBNP|254265‏
996 ‎‡2 BNE|XX5462267‏
996 ‎‡2 BNE|XX1514964‏
996 ‎‡2 BNE|XX1134205‏
996 ‎‡2 BNCHL|10000000000000000107547‏
996 ‎‡2 DNB|11878045X‏
996 ‎‡2 RERO|A003541231‏
996 ‎‡2 ISNI|0000000066329723‏
996 ‎‡2 LC|no2013011636‏
996 ‎‡2 DNB|137333277‏
996 ‎‡2 NUKAT|n 2006147892‏
996 ‎‡2 LIH|LNB:DI_w_Y;=B_z_‏
996 ‎‡2 RERO|A016393948‏
996 ‎‡2 RERO|A003541374‏
996 ‎‡2 SUDOC|114365962‏
996 ‎‡2 BNE|XX1020969‏
996 ‎‡2 ISNI|0000000021765898‏
996 ‎‡2 ISNI|0000000049846251‏
996 ‎‡2 J9U|987007592204905171‏
996 ‎‡2 BNE|XX1164877‏
996 ‎‡2 BLBNB|000559909‏
996 ‎‡2 SUDOC|182137465‏
996 ‎‡2 LC|n 82215108‏
996 ‎‡2 ISNI|0000000039934207‏
996 ‎‡2 BNF|14621930‏
996 ‎‡2 LC|ns2012000985‏
996 ‎‡2 NTA|258321636‏
996 ‎‡2 BNE|XX1408505‏
996 ‎‡2 BNE|XX6028129‏
996 ‎‡2 BNE|XX1073054‏
996 ‎‡2 SUDOC|191740063‏
996 ‎‡2 LC|nb2008005512‏
996 ‎‡2 DNB|1056310766‏
996 ‎‡2 ISNI|0000000059550462‏
996 ‎‡2 ISNI|0000000041051702‏
996 ‎‡2 SZ|1196879737‏
996 ‎‡2 SUDOC|168591499‏
996 ‎‡2 LC|n 94033857‏
996 ‎‡2 NII|DA15130291‏
996 ‎‡2 BNE|XX848472‏
996 ‎‡2 NUKAT|n 2013009955‏
996 ‎‡2 PLWABN|9810586041205606‏
996 ‎‡2 CAOONL|ncf11946469‏
996 ‎‡2 SUDOC|226974766‏
996 ‎‡2 DNB|1057131083‏
996 ‎‡2 LC|ns2014003255‏
996 ‎‡2 LC|n 2021013146‏
996 ‎‡2 PTBNP|227402‏
996 ‎‡2 PTBNP|1177727‏
996 ‎‡2 NTA|133858316‏
996 ‎‡2 RERO|A000016116‏
996 ‎‡2 SUDOC|177813547‏
996 ‎‡2 LC|no2010160406‏
996 ‎‡2 LC|no 98026201‏
996 ‎‡2 BNC|981058611431006706‏
996 ‎‡2 ISNI|0000000037088772‏
996 ‎‡2 BNE|XX824569‏
996 ‎‡2 BNE|XX4674122‏
996 ‎‡2 LC|n 97095822‏
996 ‎‡2 ISNI|0000000390678087‏
996 ‎‡2 B2Q|0001093518‏
996 ‎‡2 SUDOC|030932505‏
996 ‎‡2 ISNI|0000000118067957‏
996 ‎‡2 DNB|133294455‏
996 ‎‡2 RERO|A023717813‏
996 ‎‡2 SUDOC|031299172‏
996 ‎‡2 SUDOC|075084368‏
996 ‎‡2 NTA|121685292‏
996 ‎‡2 LC|n 2004026177‏
996 ‎‡2 LC|ns2017000600‏
996 ‎‡2 BNE|XX1588125‏
996 ‎‡2 LC|no2010133864‏
996 ‎‡2 LC|n 88002338‏
996 ‎‡2 SUDOC|144618435‏
996 ‎‡2 LC|no2018040963‏
996 ‎‡2 BNE|XX5284719‏
996 ‎‡2 PTBNP|1362157‏
996 ‎‡2 BNE|XX1347136‏
996 ‎‡2 LC|n 90709107‏
996 ‎‡2 LC|nr 93016262‏
996 ‎‡2 BNF|16134743‏
996 ‎‡2 NTA|421643277‏
996 ‎‡2 LC|ns2022000412‏
996 ‎‡2 BNC|981058520893006706‏
996 ‎‡2 BNE|XX1371612‏
996 ‎‡2 ISNI|0000000399565978‏
996 ‎‡2 BNE|XX1040332‏
996 ‎‡2 JPG|500124395‏
996 ‎‡2 ISNI|0000000059601514‏
996 ‎‡2 LC|ns2024000951‏
996 ‎‡2 PLWABN|9812830774405606‏
996 ‎‡2 LC|n 2002076668‏
996 ‎‡2 LC|no2013019633‏
996 ‎‡2 BNE|XX4606800‏
996 ‎‡2 BNCHL|10000000000000000278971‏
996 ‎‡2 LC|no2022088234‏
996 ‎‡2 BNF|13959454‏
996 ‎‡2 BNE|XX994109‏
996 ‎‡2 DNB|1216842396‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏